Oxford Healthtech Ltd. - Period Ending 2022-12-31

Oxford Healthtech Ltd. - Period Ending 2022-12-31


Oxford Healthtech Ltd. 11721747 false 2022-01-01 2022-12-31 2022-12-31 The principal activity of the company is professional, scientific and technical activities. Digita Accounts Production Advanced 6.30.9574.0 true true 11721747 2022-01-01 2022-12-31 11721747 2022-12-31 11721747 core:CurrentFinancialInstruments 2022-12-31 11721747 core:CurrentFinancialInstruments core:WithinOneYear 2022-12-31 11721747 core:PlantMachinery 2022-12-31 11721747 bus:SmallEntities 2022-01-01 2022-12-31 11721747 bus:AuditExemptWithAccountantsReport 2022-01-01 2022-12-31 11721747 bus:FullAccounts 2022-01-01 2022-12-31 11721747 bus:SmallCompaniesRegimeForAccounts 2022-01-01 2022-12-31 11721747 bus:RegisteredOffice 2022-01-01 2022-12-31 11721747 bus:Director1 2022-01-01 2022-12-31 11721747 bus:PrivateLimitedCompanyLtd 2022-01-01 2022-12-31 11721747 core:PlantMachinery 2022-01-01 2022-12-31 11721747 core:OtherRelatedParties 2022-01-01 2022-12-31 11721747 countries:EnglandWales 2022-01-01 2022-12-31 11721747 2021-12-31 11721747 core:PlantMachinery 2021-12-31 11721747 2021-01-01 2021-12-31 11721747 2021-12-31 11721747 core:CurrentFinancialInstruments 2021-12-31 11721747 core:CurrentFinancialInstruments core:WithinOneYear 2021-12-31 11721747 core:PlantMachinery 2021-12-31 iso4217:GBP xbrli:pure

Registration number: 11721747

Oxford Healthtech Ltd.

Annual Report and Unaudited Financial Statements

for the Year Ended 31 December 2022

 

Oxford Healthtech Ltd.

Contents

Balance Sheet

1

Notes to the Unaudited Financial Statements

2 to 5

 

Oxford Healthtech Ltd.

(Registration number: 11721747)
Balance Sheet as at 31 December 2022

Note

2022
£

2021
£

Fixed assets

 

Tangible assets

4

3,072

3,091

Current assets

 

Debtors

5

73,339

54,514

Cash at bank and in hand

 

90,756

35,062

 

164,095

89,576

Creditors: Amounts falling due within one year

6

(266,874)

(104,599)

Net current liabilities

 

(102,779)

(15,023)

Net liabilities

 

(99,707)

(11,932)

Capital and reserves

 

Called up share capital

150

150

Share premium reserve

59,950

59,950

Retained earnings

(159,807)

(72,032)

Shareholders' deficit

 

(99,707)

(11,932)

For the financial year ending 31 December 2022 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 20 July 2023 and signed on its behalf by:
 

.........................................
S E Huq
Director

 

Oxford Healthtech Ltd.

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2022

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
2 Old Bath Road
Newbury
Berkshire
RG14 1QL
England

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

The directors believe the going concern basis to be appropriate by virtue of the continued support of the directors and shareholders and through grant funding which will help to support the company in relation to its ongoing expenditure.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for professional, scientific and technical activies. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

Tax

The tax expense for the period comprises.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Plant and equipment

20% reducing balance

 

Oxford Healthtech Ltd.

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2022

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2021 - 2).

 

Oxford Healthtech Ltd.

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2022

4

Tangible assets

Plant and machinery
£

Total
£

Cost or valuation

At 1 January 2022

4,258

4,258

Additions

666

666

At 31 December 2022

4,924

4,924

Depreciation

At 1 January 2022

1,167

1,167

Charge for the year

685

685

At 31 December 2022

1,852

1,852

Carrying amount

At 31 December 2022

3,072

3,072

At 31 December 2021

3,091

3,091

5

Debtors

Current

2022
£

2021
£

Other debtors

73,339

54,514

6

Creditors

Creditors: amounts falling due within one year

2022
£

2021
£

Due within one year

Trade creditors

4,290

593

Taxation and social security

4,918

4,012

Other creditors

257,666

99,994

266,874

104,599

 

Oxford Healthtech Ltd.

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2022

7

Related party transactions

Other transactions with directors

S E Huq and M Y Al Aioubi are directors of the company, as at year end the company owed them £18,377 (2021: £18,377).

Summary of transactions with other related parties

At the balance sheet date the company owed £235,014 (2021: £79,703) to a shareholder in relation for an interest free loan provided to the company.